The use of vasopressin receptor antagonists in hyponatremia

Apurv Khanna, Madhav C. Menon

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Hyponatremia is the most prevalent electrolyte disorder in hospitalized patients. Vasopressin plays an important role in the pathogenesis of this disorder through its action on the vasopressin type 2 receptor (V2R), leading to electrolyte-free water reabsorption. Multiple vasopressin receptor antagonists have recently been developed that differ in their specificity for V2R and V1R. These agents have applications in diseases that can result in hypervolemic and euvolemic hyponatremia, such as the syndrome of inappropriate antidiuretic hormone secretion, congestive heart failure and cirrhosis. V2R antagonists have demonstrated promise in the short-term correction of hyponatremia, although the long-term survival benefits of these drugs are less clear. This review discusses the physiology of vasopressin in hyponatremia, the clinical implications of the disorder and examples of individual therapeutics used in treatment strategies.

Original languageEnglish
Pages (from-to)1007-1014
Number of pages8
JournalCurrent Opinion in Investigational Drugs
Issue number9
StatePublished - Sep 2010
Externally publishedYes


  • Cirrhosis
  • congestive heart failure
  • hyponatremia
  • syndrome of inappropriate antidiuretic hormone secretion
  • vasopressin antagonist


Dive into the research topics of 'The use of vasopressin receptor antagonists in hyponatremia'. Together they form a unique fingerprint.

Cite this